0001819790-24-000037.txt : 20240311 0001819790-24-000037.hdr.sgml : 20240311 20240311175755 ACCESSION NUMBER: 0001819790-24-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240307 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Azamian Bobak R. CENTRAL INDEX KEY: 0001827672 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39614 FILM NUMBER: 24739450 MAIL ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD, SUITE 160 CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001819790 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 814717861 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: (949) 409-9820 MAIL ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 4 1 wk-form4_1710194265.xml FORM 4 X0508 4 2024-03-07 0 0001819790 Tarsus Pharmaceuticals, Inc. TARS 0001827672 Azamian Bobak R. C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618 1 1 0 0 President/CEO and Board Chair 0 Stock Option (right to buy) 35.50 2024-03-07 4 A 0 136947 0 A 2034-03-06 Common Stock 136947 136947 D Restricted Stock Units 2024-03-07 4 A 0 92485 0 A Common Stock 92485 92485 D 25% of the option shares shall vest on March 7, 2025, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027, and 2028, subject to the Reporting Person's continuous service. /s/ Jeffrey Farrow, Attorney-in-Fact 2024-03-11